China Yingxia International in India
This article was originally published in The Tan Sheet
Executive Summary
The developer and manufacturer of organic nutritional food products, supplements and personal care products announces Jan. 17 its establishment of a wholly-owned subsidiary in India. "The establishment of a subsidiary in India is just one small step and much work still needs to be done before the Indian market has an impact on sales and earnings," Harbin, China-based firm's Chairman Jiao Yingxia says in a release...
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.